Given a context passage, generate a question from the passage such that its answer is shortest continous span from the passage.

Q: For Fall 2018, Berkeleys acceptance rate for freshman was 15.1%. Total enrollment was 41,910 - 30,574 undergraduate and 11,336 graduate students - with women accounting for 52.7% of undergraduates and 46.2% of graduate and professional students. Of enrolled freshman, nearly 54% were women and approximately 60% self-identified as persons of color. Enrolled freshman had an average weighted secondary school GPA of 4.45 (unweighted GPA of 3.92) and had an average SAT score of 1435 (average ACT score of 32). The interquartile range for SAT scores was 1340-1530, with 660-750 for reading/writing and 670-750 for math. Berkeleys enrollment of National Merit Scholarship Program was third in the nation until 2002, when participation in the National Merit program was discontinued. For 2016-17, Berkeley ranked fifth in enrollment of recipients of the National Merit Scholarship Program (136 scholars). 33% of admitted students receive federal Pell grants.

A: In Fall of 2018 were there more women or men enrolled as freshman?
****
Q: FK506 binding protein 6, also known as FKBP6, is a human gene.

A: In what living being can FKBP6 be found?
****
Q: Cell-mediated immunity plays a crucial role in the control of many infectious diseases, necessitating the need for adjuvants that can augment cellular immune responses elicited by vaccines. It is well established that protection against one such disease, malaria, requires strong CD8(+) T cell responses targeted against the liver stages of the causative agent, Plasmodium spp. In this report we show that the dendritic cell-specific chemokine, dendritic cell-derived CC chemokine 1 (DC-CK1), which is produced in humans and acts on naive lymphocytes, can enhance Ag-specific CD8(+) T cell responses when coadministered with either irradiated Plasmodium yoelii sporozoites or a recombinant adenovirus expressing the P. yoelii circumsporozoite protein in mice. We further show that these enhanced T cell responses result in increased protection to malaria in immunized mice challenged with live P. yoelii sporozoites, revealing an adjuvant activity for DC-CK1. DC-CK1 appears to act preferentially on naive mouse lymphocytes, and its adjuvant effect requires IL-12, but not IFN-gamma or CD40. Overall, our results show for the first time an in vivo role for DC-CK1 in the establishment of primary T cell responses and indicate the potential of this chemokine as an adjuvant for vaccines against malaria as well as other diseases in which cellular immune responses are important.

A:
Which is the causative agent of malaria?
****